Momenta Pharmaceuticals, Inc. (MNTA)

[OakesCS]

Senate healthcare bill

I'd like to know if the Senate version of the healthcare bill.
<http://help.senate.gov/BAI09A84_xml.pdf>; has any relevance to MNTA's M-Enoxaparin ANDA? I'm not clear on whether M-Enoxaparin is being treated strictly as a generic substitute for Lovenox outside the purview of this bill or if it is being treated as an "interchangeable" under the healthcare bill's language (pg 1859-1906).

If M-Enoxaparin is addressed by the healthcare bill than it appears to me that the bill eliminates simultaneous approval of multiple generic versions of Lovenox for at least 1 yr after approval of the 1st generic (pgs 1865-6).

thx,
Charlie